Table 2.
Differences of characteristics between patients with and without SBI
| No SBI (n = 2909) |
SBI (n = 263) |
P-value | |
|---|---|---|---|
| Age, y [IQR] | 56 [50–62] | 63 [57–69] | < 0.001 |
| Sex, male, n (%) | 1567 (53.9) | 146 (55.5) | 0.608 |
| Body mass index, kg/m2 [IQR] | 24.00 [22.12–25.95] | 24.24 [22.05–26.18] | 0.357 |
| Hypertension, n (%) | 619 (21.3) | 93 (35.4) | < 0.001 |
| Diabetes, n (%) | 378 (13.0) | 59 (22.4) | < 0.001 |
| Hyperlipidemia, n (%) | 737 (25.4) | 71 (27.0) | 0.562 |
| Ischemic heart disease, n (%) | 110 (3.8) | 14 (5.3) | 0.217 |
| Current smoking, n (%) | 455 (15.6) | 34 (12.9) | 0.243 |
| Current alcohol use, n (%) | 1419 (48.8) | 120 (45.6) | 0.327 |
| On antiplatelet medication, n (%) | 285 (9.8) | 41 (15.6) | 0.003 |
| On antihypertensive, n (%) | 635 (21.8) | 64 (24.3) | 0.348 |
| On statin, n (%) | 233 (8.0) | 23 (8.7) | 0.675 |
| Fasting glucose, mg/dL [IQR] | 91 [85–101] | 94 [85–109] | 0.003 |
| Total cholesterol, mg/dL [IQR] | 198 [175–223] | 191 [166–218] | 0.003 |
| LDL cholesterol, mg/dL [IQR] | 125 [102–147] | 117 [90–147] | 0.009 |
| HDL cholesterol, mg/dL [IQR] | 53 [45–63] | 51 [43–61] | 0.028 |
| Triglycerides, mg/dL [IQR] | 99 [72–144] | 107 [77–148] | 0.037 |
| TG/HDL cholesterol ratio [IQR] | 1.85 [1.22–2.98] | 2.12 [1.31–3.38] | 0.016 |
| TC/TG ratio [IQR] | 1.97 [1.39–2.69] | 1.74 [1.20–2.49] | 0.002 |
| White blood cells, × 103/μL [IQR] | 5.30 [4.40–6.36] | 5.48 [4.44–6.77] | 0.054 |
| hs-CRP, mg/dL [IQR] | 0.04 [0.01–0.15] | 0.07 [0.01–0.17] | 0.039 |
| Intracranial atherosclerosis, n (%) | 80 (2.8) | 15 (5.7) | 0.007 |
LDL low-density lipoprotein, HDL high-density lipoprotein, TG triglyceride, TC total cholesterol, hs-CRP high-sensitivity C-reactive protein